Laekna raises $61m to accelerate product development
The company launched six clinical programmes, with three multi-regional clinical trials for cancers.
Asia-Pacific
Latest in
Asia-Pacific
Takeda announces 11.6% reported revenue growth in FY2021
For the fiscal year, the operating cash flow witnessed a 11.1% rise to $8.63bn (JPY1,123.1bn).
AnGes and Eiger collaborate to distribute Zokinvy in Japan
AnGes will make upfront and milestone payments up to $1.5m to Eiger, under the deal.
Orion and Jemincare sign deal to develop non-opioid drug for pain
Jemincare will receive an upfront payment of $16m from Orion, as well as milestone and royalty payments.
DCGI grants emergency use approval for Bharat Biotech’s Covaxin in children
In December last year, the DCGI approved the vaccine for emergency use in children of the age 12 to 18…
Astellas and University of Tokyo extend partnership to develop therapies
New projects will use the scientific research of the University of Tokyo with Astellas’ drug discovery expertise.
Porton and Sinorda partner to develop cell and gene therapies
Under the deal, Porton will offer services to develop breakthrough cell therapies of Sinorda.
Samsung Biologics acquires Samsung Bioepis joint venture for $2.3bn
The takeover will offer Samsung Biologics with biosimilar development expertise and future performance in new drug development.